Susquehanna International Group, LLP Omega Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1.22 - $2.25 $366 - $675	300 Added 1.53%	19,900 $24,000
Q2 2024 Aug 15, 2024	SELL	$1.86 - $3.2 $26,970 - $46,400	-14,500 Reduced 42.52%	19,600 $40,000
Q1 2024 May 07, 2024	BUY	$2.73 - $5.32 $45,591 - $88,844	16,700 Added 95.98%	34,100 $124,000
Q4 2023 Feb 14, 2024	SELL	$1.35 - $3.21 $11,070 - $26,322	-8,200 Reduced 32.03%	17,400 $52,000
Q3 2023 Nov 14, 2023	SELL	$2.15 - $5.68 $17,630 - $46,576	-8,200 Reduced 24.26%	25,600 $55,000
Q2 2023 Aug 11, 2023	BUY	$5.6 - $9.66 $45,920 - $79,212	8,200 Added 32.03%	33,800 $189,000
Q1 2023 May 16, 2023	BUY	$4.81 - $10.95 $123,135 - $280,320	25,600 New	25,600 $154,000
Q3 2022 Nov 14, 2022	BUY	$3.63 - $6.65 $76,956 - $140,980	21,200 New	21,200 $115,000

43.4M

25.8K

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $36.8M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.